ENSC Stock Analysis: Buy, Sell, or Hold?
ENSC - Ensysce Biosciences, Inc. Common Stock
$0.52
0.00 (-0.78%)
▼
5d:
+105.61%
30d:
+87.8%
90d:
+40.59%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 12, 2026
3d
Get Alerted When ENSC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ENSC is 40.6% above its trading range ($0.37). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ENSC is 40.6% above its trading range ($0.37). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ENSC is currently trading at $0.52, which is considered extended relative to its 30-day fair value range of $0.23 to $0.37.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.98.
Market Sentiment: ENSC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.45 (+3062.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENSC is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.98.
Market Sentiment: ENSC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $16.45 (+3062.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.23 -
$0.37
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+40.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 3062.2% below Wall St target ($16.45)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.23 -
$0.37
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.98
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.73
Wall Street Target
$16.45
(+3062.2%)
Revenue Growth (YoY)
-27.2%
Profit Margin
-250.4%
Share & Embed Analysis
Last updated: August 08, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:25 AM
Data refreshes hourly during market hours. Next update: 6:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 48 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
